Watermark
  Back to Search Results

BGB-53038-101

Recruiting

A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

Ask to Join

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-53038-101

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT06585488

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2024-514704-13-00

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

No Study Documents